Geriatric Healthcare Specialist Jonesboro AR

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment.

James Mark Robinette
(870) 932-2423
801 Osler Dr Ste A
Jonesboro, AR
Specialty
Family Practice, Geriatric Medicine

Data Provided by:
Terry Dean Weaver, MD
(808) 523-8461
528 E Washington Ave
Jonesboro, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: In Univ Sch Of Med, Indianapolis In 46202
Graduation Year: 1995

Data Provided by:
Burcu Ozdemir
(501) 686-8000
4301 W Markham St # 783
Little Rock, AR
Specialty
Geriatric Medicine

Data Provided by:
Victoria Akins, MD
(501) 686-8073
Slot 547-13 4301 W Markham St
Little Rock, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Univ Of Ar Coll Of Med, Little Rock Ar 72205
Graduation Year: 1989

Data Provided by:
Bilal Naeem, MD
3715 N Business Dr
Fayetteville, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Dow Med Coll, Univ Of Karachi, Karachi, Pakistan
Graduation Year: 1991

Data Provided by:
Thomas Mulligan
(870) 336-5080
303 E Matthews Ave Ste 202
Jonesboro, AR
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
David Arnold Lipschitz, MD
(501) 614-2000
4301 W Markham St
Little Rock, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of The Witwatersrand, Med Sch, Johannesburg, So Africa
Graduation Year: 1966

Data Provided by:
Jennifer Allyn Dillaha, MD
(501) 280-4055
4815 West Markham St Slot 41
Little Rock, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine, Infectious Diseases
Gender
Female
Education
Medical School: Univ Of Ar Coll Of Med, Little Rock Ar 72205
Graduation Year: 1994

Data Provided by:
Pham Hieu Liem, MD
(501) 686-8948
4301 W Markham St
Little Rock, AR
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Male
Education
Medical School: Med & Pharm Univ, Ho Chi Minh City, Viet Nam (840-01 Prior 1/71)
Graduation Year: 1973

Data Provided by:
Ikemefuna Wilfred Onyia, MD
288 W Tyler Ave
West Memphis, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Nigeria, Coll Of Med, Enugu, Anambra, Nigeria
Graduation Year: 1993

Data Provided by:
Data Provided by:

Food for Thought

Provided by: 

By Kris Kucera

Rarely does an extended family get a free pass from Alzheimer’s disease or diabetes mellitus. On the surface, these two afflictions appear totally unrelated —Alzheimer’s (AD), Mother Nature’s cruel version of identity theft; and diabetes, the glucose-metabolism disorder that affects both young and old alike. However, new research indicates that the two diseases behave in a similar manner.

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment. This, they say, suggests that a form of diabetes, tentatively dubbed type 3, leads to AD.

Type 1 diabetes results from a severe or complete lack of insulin, a hormone made in the pancreas that controls blood sugar. Type 2, dubbed adult onset diabetes (although these days it occurs in teenagers and even younger kids), also stems from a dearth of insulin, or insulin resistance —the existing insulin molecules cannot deliver glucose through the cells’ membranes. Surprisingly, the researchers found a new form of insulin, produced in the brain, and they believe that, over time, decreasing levels of this “brain insulin” and other insulin-related proteins ultimately precipitate AD. While levels of brain insulin have no known affect on a body’s overall blood sugar, scientists have long recognized that diabetes patients are more likely to develop AD than those without the disease.

Skeptics of the Brown team’s findings argue that our brains produce so little insulin in the first place, reduced levels of the hormone can’t possibly play a significant role in AD. Regardless, the new data show that AD may be a neuroendocrine disorder, thus increasing the possibility for more effective treatments. And that gives hope to all of us who may one day be touched, directly or indirectly, by the merciless hand of AD.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...